See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Caesar Yaro

Caesar Yaro

Caesar Yaro

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

GlucoBurst Glucose Gel

Bill Rodman

GlucoBurst Glucose Gel

Glucagon

Updated 7 weeks ago
Stress-Induced Hormone Imbalances Go Far Beyond Insulin in Diabetes
Feb 3, 2014 | 
Virtually anything from the stress of a long checkout line to the first signs of menopause can trigger hormone imbalances, which reveal themselves through mood swings, fatigue, migraines, memory problems, and a lackluster sex drive.
Glucagon Study Shows Promise for Type 1s
Sep 8, 2013 | 
In the healthcare field today, perhaps no area holds as much promise and as many perils as weight control. Researchers see the same statistics that the rest of us do. They see the upcoming wave of obesity and diabetes diagnoses. They see the myriad complications that spring up from these conditions. And they want to address the problem in a simple way.
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Caesar Yaro

Caesar Yaro

Caesar Yaro

ARKRAY introduces The GLUCOCARD™ X-METER

Becky Brown

ARKRAY introduces The GLUCOCARD™ X-METER

GlucoBurst Glucose Gel

Bill Rodman

GlucoBurst Glucose Gel

Taiwanese Study Identifies Top Three Drugs for Type 2 Glycemic Control
May 16, 2012 | 
Researchers in Taipei, Taiwan, report that they have identified the top three drugs for reducing A1C levels in type 2 diabetes: biphasic insulin, GLP-1 analogs, and basal insulin. They hedged a little on their endorsement of GLP-1 analogs, however, by saying that although they are not decisively better at controlling A1Cs than other oral diabetes drugs, they have the advantage of helping to reduce weight without adding to the danger of hypoglycemia.
Molecular Switch Could Be Key for Type 2s
May 13, 2012 | 
With tens of millions of American facing life with type 2 diabetes and many millions more at risk of the disease, scientists are scrambling to unravel novel treatments. The latest breakthrough could come from California's Salk Institute.
FDA OKs Sale of Combo Drug JANUMET® XR
Feb 6, 2012 | 
The FDA has approved US sales of JANUMET® XR, a daily oral treatment for type 2 diabetes that combines sitagliptin and extended-release metformin. The drug is the fourth oral type 2 diabetes treatment introduced by Merck, which also sells JANUVIA, JANUMET, and JUVISYNC.
 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.